A recent study from Sweden shows promising advancements in diagnosing Alzheimer’s disease with a blood test. The test measures specific protein ratios in the blood and combines this with an amyloid probability score (APS2) to accurately diagnose Alzheimer’s. This method matches or even surpasses the accuracy of specialists and primary care doctors.

Researchers tested blood samples from patients with early cognitive symptoms and found that this approach delivered highly accurate diagnoses. It worked well across different patient groups and healthcare settings, making it a reliable tool for various care facilities.

These findings suggest that this blood test could revolutionize Alzheimer’s diagnosis. It offers a non-invasive, accessible, and accurate method, potentially improving early detection and treatment, enhancing patient outcomes, and reducing the burden on specialized diagnostic centers.

SOURCE:

News Medical, July 29,2024